Chlorpheniramine 8 mg / methscopolamine 2.5 mg / phenylephrine 25 mg 12HR Extended Release Oral Tablet (14) / brompheniramine 6 mg / pseudoephedrine 45 mg Extended Release Oral Tablet (14) Pack
RxNorm 759494

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 759494 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: chlorpheniramine 8 mg / methscopolamine 2.5 mg / phenylephrine 25 mg 12HR Extended Release Oral Tablet (14) / brompheniramine 6 mg / pseudoephedrine 45 mg Extended Release Oral Tablet (14) Pack.

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Chlorpheniramine 8 mg / methscopolamine 2.5 mg / phenylephrine 25 mg 12HR Extended Release Oral Tablet (14) / brompheniramine 6 mg / pseudoephedrine 45 mg Extended Release Oral Tablet (14) Pack
AUI:10823874
View
GPCK
{14 (12 HR brompheniramine maleate 6 mg / pseudoephedrine hydrochloride 45 mg Extended Release Oral Tablet) / 14 (12 HR chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 25 mg Extended Release Oral Tablet) } Pack
AUI:12372763
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSN

Prescribable Name (PSN):
Chlorpheniramine 8 mg / methscopolamine 2.5 mg / phenylephrine 25 mg 12HR Extended Release Oral Tablet (14) / brompheniramine 6 mg / pseudoephedrine 45 mg Extended Release Oral Tablet (14) Pack
(Atom ID: 10823874)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
chlorpheniramine 8 MG / methscopolamine 2.5 MG / phenylephrine 25 MG 12HR Extended Release Oral Tablet (14) / brompheniramine 6 MG / pseudoephedrine 45 MG Extended Release Oral Tablet (14) Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
759494
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
10823874
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
759494
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
GPCK

Generic Pack (GPCK):
{14 (12 HR brompheniramine maleate 6 mg / pseudoephedrine hydrochloride 45 mg Extended Release Oral Tablet) / 14 (12 HR chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 25 mg Extended Release Oral Tablet) } Pack
(Atom ID: 12372763)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{14 (12 HR brompheniramine maleate 6 MG / pseudoephedrine hydrochloride 45 MG Extended Release Oral Tablet) / 14 (12 HR chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / phenylephrine hydrochloride 25 MG Extended Release Oral Tablet) } Pack
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
759494
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12372763
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
GPCK
Generic Pack ({# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack)
Source Code
759494
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Brompheniramine


Brompheniramine relieves red, irritated, itchy, watery eyes; sneezing; and runny nose caused by allergies, hay fever, and the common cold. Brompheniramine helps control symptoms, but does not treat the cause of the symptoms or speed recovery. Brompheniramine should not be used to cause sleepiness in children. Brompheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
[Learn More]


Pseudoephedrine


Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.
[Learn More]


* Please review the disclaimer below.